Global Contraceptives Market Report 2021: Market to Reach $29.1 Billion by 2027 - Unmet Contraception Needs Signals Huge Market Penetration Opportunities
Dublin, Aug. 18, 2021 (GLOBE NEWSWIRE) -- The "Contraceptives - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
Global Contraceptives Market to Reach $29.1 Billion by 2027
Amid the COVID-19 crisis, the global market for Contraceptives estimated at US$21.7 Billion in the year 2020, is projected to reach a revised size of US$29.1 Billion by 2027, growing at a CAGR of 4.3% over the period 2020-2027.
Drugs, one of the segments analyzed in the report, is projected to record 4.6% CAGR and reach US$18.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Devices segment is readjusted to a revised 3.7% CAGR for the next 7-year period.
The U.S. Market is Estimated at $5.8 Billion, While China is Forecast to Grow at 7.7% CAGR
The Contraceptives market in the U.S. is estimated at US$5.8 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$6.3 Billion by the year 2027 trailing a CAGR of 7.7% over the analysis period 2020 to 2027.
Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.4% and 3.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.2% CAGR.
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Contraceptives: Transforming Birth Control, Planned Parenthood, and Women's Health
Contraceptives Market: Fast Facts
The Vital Need to Curtail the Ballooning Global Population through Birth Control:
Effectiveness Index of Contraceptive Methods: Brief Details of Method, Efficacy Percentage, Benefits, Risks, and Availability
Unmet Contraception Needs Signals Huge Market Penetration Opportunities
Global Population Statistics: Unfurling the Market Potential
China & India: Two Countries with the Largest Sexually Active Population Offer Significant Growth Opportunities
Global Market Outlook
2. FOCUS ON SELECT PLAYERS
Agile Therapeutics, Inc.
Allergan plc
Ansell Limited
Bayer AG
Church & Dwight Co., Inc.
CooperSurgical Inc.
Fuji Latex Co. Ltd.
Janssen Pharmaceuticals, Inc.
Karex Berhad
Mankind Pharma Ltd.
Okamoto Industries, Inc.
Pfizer Inc.
Piramal Enterprises Ltd.
Reckitt Benckiser Group Plc.
Sagami Rubber Industries Co., Ltd.
Teva Pharmaceutical Industries Ltd.
Thai Nippon Rubber Industry Co., Ltd.
3. MARKET TRENDS & DRIVERS
Condoms as a Powerful Tool against HIV/AIDS and Other STIs Witness Strong Growth in Demand
Condoms: Percentage Effectiveness of Protection against STDs
Contraceptive Innovations and Advancements: Spearheading Growth
Major Condom Innovations
Declining Prices and Increased Accessibility of Contraceptives Benefit Market Expansion
Despite Waning Popularity, Oral Contraceptives Continue to Sustain Market Domination
Rising Need to Develop Contraceptives for Men Drive Robust Research & Development
Evolving Designs and Features in Female Condoms Drive Surging Popularity and Growing Adoption
Increasing Standard of Living: A Key Growth Driver
Social Stigmas in Under Developed Countries Hamper Market Prospects
Major Hindrances for Widespread Usages of Condoms
Developing Countries Continue to Drive Current and Future Market Growth
Manufacturers Depend on Emerging Markets to Increase Sales Momentum
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
United States
Canada
Japan
China
Europe
France
Germany
Italy
United Kingdom
Spain
Russia
Rest Of Europe
Asia-Pacific
Australia
India
South Korea
Rest Of Asia-Pacific
Latin America
Argentina
Brazil
Mexico
Rest Of Latin America
Middle East
Iran
Israel
Saudi Arabia
United Arab Emirates
Rest Of Middle East
Africa
IV. COMPETITION
Total Companies Profiled: 92
For more information about this report visit https://www.researchandmarkets.com/r/ti8ine
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900